Zoetis ZTS
NYSE ZTS
$73.31 -0.25 (-0.34%)
As of: Sep 9, 2026 · 3:59 PM EDT

Zoetis (ZTS) Non-Current Deferred Tax Liability (2012 - 2026)

Zoetis' (ZTS) quarterly Non-Current Deferred Tax Liability came in at $122.0 million in Q2 2026, down 21.79% year-over-year from $156.0 million in Q2 2025, and down 6.15% quarter-over-quarter from $130.0 million in Q1 2026.

Analysis

Zoetis (ZTS) Non-Current Deferred Tax Liability (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Non-Current Deferred Tax Liability for 15 consecutive years, with $122.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 21.79% year-over-year to $122.0 million in Q2 2026; TTM through Jun 2026 was $122.0 million, a 21.79% decrease from a year earlier, with the FY2025 full-year figure at $137.0 million, down 17.96% from the prior year.
  • Non-Current Deferred Tax Liability was $122.0 million for Q2 2026 at Zoetis, down from $130.0 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $287.0 million in Q1 2022 and troughed at $121.0 million in Q2 2023.
  • A 5-year average of $167.8 million and a median of $151.5 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability tumbled 55.84% in 2023 and surged 44.63% in 2024, its largest moves.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $142.0 million in 2022, then increased by 2.82% to $146.0 million in 2023, then increased by 14.38% to $167.0 million in 2024, then decreased by 17.96% to $137.0 million in 2025, then decreased by 10.95% to $122.0 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $122.0 million (Q2 2026), $130.0 million (Q1 2026), and $137.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Idexx Laboratories 42.23 Bn 42.03 Bn 779.09 Mn
2 Zoetis 31.39 Bn 29.72 Bn 1.05 Bn
3 Elanco Animal Health 12.21 Bn 11.68 Bn 798.00 Mn
4 Phibro Animal Health 1.55 Bn 1.47 Bn 134.40 Mn
5 Immucell 89.91 Mn 81.05 Mn 2.44 Mn
6 Zhengye Biotechnology Holding 76.30 Mn 77.22 Mn -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 122.00 Mn
Mar 31, 2026 130.00 Mn
Dec 31, 2025 137.00 Mn
Sep 30, 2025 147.00 Mn
Jun 30, 2025 156.00 Mn
Mar 31, 2025 161.00 Mn
Dec 31, 2024 167.00 Mn
Sep 30, 2024 172.00 Mn
Jun 30, 2024 175.00 Mn
Mar 31, 2024 136.00 Mn
Dec 31, 2023 146.00 Mn
Sep 30, 2023 160.00 Mn
Jun 30, 2023 121.00 Mn
Mar 31, 2023 131.00 Mn
Dec 31, 2022 142.00 Mn
Sep 30, 2022 256.00 Mn
Jun 30, 2022 274.00 Mn
Mar 31, 2022 287.00 Mn
Dec 31, 2021 320.00 Mn
Sep 30, 2021 291.00 Mn